Hope for Huntington's: new pill aims to tame harmful proteins

NCT ID NCT07537075

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests an oral drug called SKY-0515 in 500 adults with Huntington's disease who have already completed a prior study of the same drug. The goal is to see if the drug can safely lower harmful proteins and improve symptoms over the long term. Participants must be 25 or older and have a genetic confirmation of Huntington's disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON'S DISEASE (HD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Huntington disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Calvary Health Care Bethlehem

    Caulfield South, Victoria, 3162, Australia

  • Flinders Medical Centre

    Adelaide, South Australia, 5042, Australia

  • The Royal Melbourne Hospital

    Parkville, Victoria, 3050, Australia

  • Westmead Hospital

    Westmead, New South Wales, 2145, Australia